We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




BioTek Receives European Patent for Ultrasonic Cleaning Technology

By LabMedica International staff writers
Posted on 13 Jun 2012
BioTek Instruments, Inc. More...
(BioTek; Winooski, VT, USA), a microplate instrumentation, automation, and software developer, has announced receipt of European Patent EP 2 093 572 B, which covers the ultrasonic cleaning and maintenance feature used in the company’s microplate washers.

The high-performance cleaning technology, known as Ultrasonic Advantage, is incorporated into the majority of BioTek's microplate washers, including the 405 Touch, 405 LS, Elx405 Select Deep Well Microplate Washers, and the EL406 Microplate Washer Dispenser. Easily operable and cost-effective, the company’s microplate washers incorporate technology that allows for both strip washing and full plate washing in a full range of configurations.

Using ultrasonic sound waves, Ultrasonic Advantage eliminates residue attached on the mircroplate as well as reduces salt crystal build-up and protein, which contributes to assay failure. The feature may be initiated from the washer's keypad interface or optional Liquid Handling Control software for unattended washer manifold maintenance.

BioTek provides innovative instruments and testing products that help accelerate life science research, as well as offers solutions for the hospital safety and quality assurance markets.

Patent for Ultrasonic Advantage is pending in the United States.

Related Links:


BioTek Instruments, Inc.



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.